SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (3308)6/15/2021 3:48:58 PM
From: CuttingEdge Bio  Read Replies (1) | Respond to of 3557
 
I thought the answer was spot on, and the question is bogus or a red herring. What matters is safety and efficacy. If it was causing 10 times the AEs, then obviously it can't compete. If it was not as efficacious, then obviously can't compete. Neither are true. Why would the difference in dose matter?